BioSpace News Archive

Business

Herbert Boyer, Pioneering Geneticist and Co-founder of Today’s Biotech Industry, Joins GATC Health’s Board of Advisors

GATC Health Corp announced that Herbert Boyer has joined GATC Health’s board of advisors.

March 2, 2023
·
3 min read
Business

Dyne Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

Dyne Therapeutics, Inc. today reported financial results for the fourth quarter and full year 2022 and business highlights.

March 2, 2023
·
8 min read
Pharm Country

Frontiers in Immunology Publishes Pre-Clinical Study of Palatin’s Oral Formulation of PL8177 Demonstrating Therapeutic Effects in Inflammatory Bowel Disease

Palatin Technologies, Inc. today announced Frontiers in Immunology published a manuscript, “A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs and humans.”

March 2, 2023
·
7 min read
Business

Expansion Therapeutics Announces Key Additions and Updates to Scientific Advisory Board

Expansion Therapeutics, Inc. today announced the addition of Kenneth S. Kosik, M.D., Leonard Petrucelli, Ph.D., and Melissa A. Starovasnik, Ph.D., to its Scientific Advisory Board (SAB).

March 2, 2023
·
5 min read
Drug Development

Galectin Therapeutics Provides Final Randomization Status of NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Liver Cirrhosis Caused by Non-Alcoholic Steatohepatitis

Galectin Therapeutics, Inc. announced that in late December 2022, it ended the enrollment of new patients into NAVIGATE, its seamless, adaptive, phase 2b/3 study of belapectin in patients with liver cirrhosis caused by non-alcoholic steatohepatitis (NASH).

March 2, 2023
·
7 min read
Biotech Beach

aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2022 Financial Results Management to host conference call and webcast on March 9th at 5:00 pm EST / 2:00 pm PST

aTyr Pharma, Inc. today announced that it will report fourth quarter and full year 2022 financial results and provide a corporate update after the market close on Thursday, March 9, 2023.

March 2, 2023
·
1 min read
Drug Development

BioVie Announces Completion of Patient Enrollment in Phase 3 Trial Assessing NE3107 in Alzheimer’s Disease

BioVie Inc. today announced that its NM101 trial evaluating NE3107 in the treatment of patients with Alzheimer’s Disease, has achieved its revised enrollment target of 400 patients.

March 2, 2023
·
6 min read
Vaxxinity to Present at Upcoming March Scientific and Medical ConferencesVaxxinity to present new preclinical data on anti-tau Alzheimer’s vaccine candidate VXX-301 at AD/PD International Conference

Vaxxinity, Inc. today announced that its scientists and executives will present at three upcoming scientific and medical conferences in March.

March 2, 2023
·
3 min read
Business

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 9, 2023

Lineage Cell Therapeutics, Inc. today announced that it will report its fourth quarter and full year 2022 financial and operating results on Thursday, March 9, 2023, following the close of the U.S. financial markets.

March 2, 2023
·
2 min read
Business

Personalis Appoints Christopher Hall as Chief Executive Officer

Personalis, Inc., a leader in advanced genomics for precision oncology, announced that its Board of Directors has appointed Christopher Hall as Chief Executive Officer and a member of the Board, effective immediately, in addition to his role as President.

March 2, 2023
·
6 min read